MedTrace Logo

Determining the Minimal Effective Dose of Static Stretching for Increasing Range of Motion in Adults

NCT06960590 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 51

Last updated 2025-07-11

No results posted yet for this study

Summary

The study is planned to be conducted in 2025. The methods used in the study are non-invasive methods. The study groups will perform 1 to 3 static stretching sessions per week. The number of series per session will be from 1 to 3. The static stretching time of the back band in the series will be from 20 s to 60 s. The total stretching time per week will be from 45 s to 135 s. The break between series will be 45 s, and the duration of the intervention will be from 6 to 8 weeks. During stretching, the subject maintains a maximum bend with straight knee joints for a specified time. Before starting the study, participants will undergo a toe-to-floor test to assess the flexibility of the back band. The test will be repeated after the intervention. The aim of the study is to determine the minimum effective dose of static stretching. Currently, anecdotal evidence suggests that this dose is 90 seconds of static stretching per week.

The study does not involve any likelihood of harm to study participants as a result of participating in the study.

Conditions

  • Static Stretching

Interventions

OTHER

Training - static streching

The intervention group performed one training session per week. Each training session consisted of 2 series of static stretching of the back band. The rest time between series was 45 s. The intervention lasted 6 weeks.

Sponsors & Collaborators

  • Józef Piłsudski University of Physical Education

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
25 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-03-25
Primary Completion
2025-08-05
Completion
2025-08-06

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06960590 on ClinicalTrials.gov